Detalhe da pesquisa
1.
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Lancet Oncol
; 25(4): 463-473, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467131
2.
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination.
Blood
; 139(5): 678-685, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861036
3.
Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects.
J Infect Chemother
; 30(3): 271-275, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944697
4.
Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry.
J Am Chem Soc
; 145(6): 3346-3360, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738297
5.
Improved outcomes in patients with chronic lymphocytic leukaemia infected during the omicron BA.5 subvariant surge.
Br J Haematol
; 201(6): 1125-1128, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042235
6.
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Blood
; 137(23): 3165-3173, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33861303
7.
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Eur J Haematol
; 111(1): 63-71, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964939
8.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol
; 98(12): 1856-1868, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772428
9.
BNT162b2 mRNA COVID-19 vaccine booster induces seroconversion in patients with B-cell non-Hodgkin lymphoma who failed to respond to two prior vaccine doses.
Br J Haematol
; 196(6): 1329-1333, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075635
10.
Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.
J Med Virol
; 94(3): 1241-1245, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755363
11.
Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study.
Haematologica
; 107(5): 1111-1118, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233446
12.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083525
13.
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cells.
Eur J Haematol
; 108(1): 52-60, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564876
14.
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
Br J Haematol
; 195(2): 186-193, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196388
15.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Lancet
; 395(10232): 1278-1291, 2020 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305093
16.
Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.
Eur J Nucl Med Mol Imaging
; 48(11): 3540-3549, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966088
17.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
18.
Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs.
J Am Chem Soc
; 142(27): 11734-11742, 2020 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369353
19.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096887
20.
CD74 is a novel transcription regulator.
Proc Natl Acad Sci U S A
; 114(3): 562-567, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031488